Dr. Bhuvan Chugh

Dr. Bhuvan Chugh
Medical Oncology

Oncology
DNB, MBBS
8 years of experience
Max Super Specialty Hospital Gurgaon

About

Dr Bhuvan Chugh is a Medical Oncologist with rich experience in the treatment of solid organ cancers. He has a special interest in breast, thoracic, head & neck and hepato-billiary malignancies. He is the convener for the molecular tumour board at Max Saket and Gurgaon and has a keen interest in precision medicine. He has been an active part of the faculty both in terms of clinical and research work. Have co-authored many chapters, papers & abstracts in various national and international journals and conferences.

List of Treatments
  • Anal Cancer
  • Breast Biopsy
  • Cervical Cancer
  • Chemotherapy
  • Fallopian Tube Cancer
  • Kidney Cancer Treatment
  • Lutetium Therapy
  • Metastatic Cancer
  • Pancreatic Cancer
  • Pet Scan
  • Psma Therapy
  • Sarcoma
  • Tace For Cancer
  • Vaginal Cancer Treatment
  • Whipple Surgery
  • Spine Tumour Surgery
  • Gallbladder Cancer
  • HIPEC
  • Hodgkin Disease
  • Immunotherapy
  • Kidney Cancer
  • Lung Cancer
  • Oral Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Liver Cancer
  • Breast Cancer-Surgical
  • Wilms Tumor
  • Breast Cancer
  • Gastric Bypass
  • GIST Treatment
  • Gall Bladder
Publications
  • Chugh, B. and Vaid, A K. 2020. ‘Key Takeaways from International Guidelines on Gastric Cancer’. Gastric Cancer. Springer Healthcare Education
  • Clinico-hematologic and cytogenetic profile in a rare case of pure erythroid leukaemia; Annals of Haematology 98(3); March 2019.
  • Myelodysplastic syndromes: Where do we stand? Asian Journal of Oncology. April 2016.
  • Outcomes of patients presenting with acute coronary syndrome with vitamin D deficiency. Indian Heart Journal. November 2014.

       PRESENTATIONS

  • Abstract Publication in BTG2018, 9th International Hematologic Malignancies Conference held in Seoul, South Korea from March 29-31, 2018.
  • A Prospective Study of Clinico-pathological features, Prognostic factors, and Response rates in Advanced Non-small Cell Lung Cancer Patients Eligible for Chemotherapy - A Single Centre Experience at 37th ICON New Delhi. 2017
  • A Prospective Observational Study of Clinico-Pathological Features, Prognostic Factors and Treatment Response to Primary Therapy in Multiple Myeloma at a Tertiary Care Centre; Blood 134(Supplement_1):5559-5559; November 2019
  • Speaking engagements in various national level conferences

Similar Doctor in India